Eisai Co., Ltd. Skip Navigation Top menu Japanese | English
| Sitemap |
   Home > Investor Relations Main contents

Investor Relations Understanding Eisai
Pick up
Understanding
Management

 Business Performance Highlights

  Performance Highlights, Research & Development

 Financial Information

  Annual Financial Results, Reference Data etc

 Presentations

  Financial Explanation, Information Meeting etc

 Annual Report

  Reports have been Issued since 1997

 IR Calendar

  Past and Upcoming IR Events

 Share Information

  Share Price Information etc

   General Meeting of Shareholders

 

 Bonds and Ratings

  Bond Issues, Ratings by Independent ratings agencies

 Analyst Coverage

  List of Analysts taking charge of Eisai

 IR Site Map

  Site Map on IR Page

 IR Inquiry

  Inquiry about Eisai

Investor Kit
   Latest Investor Kit is available for download
Understanding Eisai
   Eisai has launched a brand new web content “Understanding Eisai”, which contains basic information about Eisai

  News Release
list
September 2, 2010
EISAI ANNOUNCES THE START OF THE FIRST CLINICAL STUDY OF BAN2401, A NOVEL MONOCLONAL ANTIBODY TARGETING THE NEUROTOXIC PROTOFIBRILS BELIEVED TO CAUSE ALZHEIMER'S DISEASE
August 30, 2010
EISAI ANNOUNCES EXTENSION OF FDA REVIEW OF DRUG APPLICATION FOR INVESTIGATIONAL AGENT ERIBULIN MESYLATE
August 30, 2010
Abbott Japan and Eisai Submit Application for Additional Indication of Humira®, a Fully Human Anti-TNFalpha Monoclonal Antibody, for the Treatment of Juvenile Idiopathic Arthritis in Japan

  IR What's New
August 2, 2010
First Quarter Financial Results Explanation for the Fiscal Year Ending March 31, 2011 [Material, Webcast]
July 30, 2010
First Quarter Financial Results for the Fiscal Year Ending March 31, 2011
July 29, 2010
Annual Report 2010

  Information
Corporate Governance Report updated (July 30, 2010)
Notice of shareholder voting results for the 98th ordinary general meeting of shareholders (June 21, 2010)
Notice of resolutions of the 98th ordinary general meeting of shareholders (June 18, 2010)
 Share Performance 
Open a separate window

    (delayed 20 min.)
Side menu
Message for Investors
IR Cafe
Top 5 most viewed pages
(July 2010)
1. Presentations
2. Financial Reports
3. Business Performance Highlights
4. IR Calendar
5. General Meeting of Shareholders
Eisai Glossary
E-mail Alerts


Bottom menu
   Privacy Policy  |   Terms of Use  |   Accessibility
Copyright(C) Eisai Co., Ltd All right reserved.